FdaApplication
NDA 022569
Identifiers
- fda_app_no: NDA022569
Properties
| Property | Value |
|---|---|
| applicant_name | BTCP PHARMA LLC |
| application_type | NDA |
| approval_date | 2011-06-30 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LAZANDA | FENTANYL CITRATE | EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SPRAY, METERED;NASAL |
| LAZANDA | FENTANYL CITRATE | EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SPRAY, METERED;NASAL |
| LAZANDA | FENTANYL CITRATE | EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SPRAY, METERED;NASAL |
3 products